BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
Conditions:   Colorectal Cancer;   Pancreatic Cancer;   Gastric Cancers;   Cholangiocarcinoma
Intervention:   Drug: BOLD-100 in combination with FOLFOX Chemotherapy
Sponsor:   Bold Therapeutics, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

August 20, 2022Comments OffClinicalTrials.gov | Gastroenterology Clinical Trials | Gastroenterology Studies | US National Library of Medicine
Comments